Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jazz Pharmaceuticals (DE:J7Z)
FRANKFURT:J7Z
Jazz Pharmaceuticals (J7Z) Stock Price & Analysis
1 Followers
J7Z Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€101.30 - €134.35
Previous Close€106.8
Volume2.00
Average Volume (3M)28.00
Market Cap
€6.70B
Enterprise Value€10.80B
Total Cash (Recent Filing)$1.34B
Total Debt (Recent Filing)$5.78B
Price to Earnings (P/E)N/A
Beta0.26
Next Earnings
May 07, 2024EPS Estimate
€3.88Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding62,345,283
10 Day Avg. Volume16
30 Day Avg. Volume28
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)-2.11
Price to Sales (P/S)1.82
Price to Cash Flow (P/CF)10.80
P/FCF Ratio9.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.85
Enterprise Value/Gross Profit2.57
Enterprise Value/Ebitda18.41
Forecast
1Y Price Target
€175.26Price Target Upside64.10% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
Jazz Pharmaceuticals News
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
0.44% Other Institutional Investors
99.56% Public Companies and
Individual Investors
J7Z FAQ
What was Jazz Pharmaceuticals’s price range in the past 12 months?
Jazz Pharmaceuticals lowest stock price was €101.30 and its highest was €134.35 in the past 12 months.
What is Jazz Pharmaceuticals’s market cap?
Currently, no data Available
When is Jazz Pharmaceuticals’s upcoming earnings report date?
Jazz Pharmaceuticals’s upcoming earnings report date is May 07, 2024 which is in 11 days.
How were Jazz Pharmaceuticals’s earnings last quarter?
Jazz Pharmaceuticals released its earnings results on Feb 28, 2024. The company reported €4.633 earnings per share for the quarter, missing the consensus estimate of €4.785 by -€0.152.
Is Jazz Pharmaceuticals overvalued?
According to Wall Street analysts Jazz Pharmaceuticals’s price is currently Undervalued.
Does Jazz Pharmaceuticals pay dividends?
Jazz Pharmaceuticals does not currently pay dividends.
What is Jazz Pharmaceuticals’s EPS estimate?
Jazz Pharmaceuticals’s EPS estimate is €3.88.
How many shares outstanding does Jazz Pharmaceuticals have?
Currently, no data Available
What happened to Jazz Pharmaceuticals’s price movement after its last earnings report?
Jazz Pharmaceuticals reported an EPS of €4.633 in its last earnings report, missing expectations of €4.785. Following the earnings report the stock price went down -9.162%.
Which hedge fund is a major shareholder of Jazz Pharmaceuticals?
Among the largest hedge funds holding Jazz Pharmaceuticals’s share is Polaris Capital Management LLC. It holds Jazz Pharmaceuticals’s shares valued at 156M.
---
Jazz Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€175.26 (64.10% Upside)
€175.26 (64.10% Upside)
Blogger Sentiment
Bullish
DE:J7Z Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Bought Shares
Worth $997.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.13%
12-Months-Change
Fundamentals
Return on Equity
12.16%
Trailing 12-Months
Asset Growth
5.15%
Trailing 12-Months
Company Description
Jazz Pharmaceuticals
Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.
---
J7Z Earnings Call
Q4 2024
0:00 / 0:00
---
J7Z Stock 12 Months Forecast
Average Price Target
€175.26
▲(64.10% Upside)
Technical Analysis
Best Analysts Covering J7Z
1 Year
1 Year Success Rate
10/20 ratings generated profit
1 Year Average Return
+3.90%
reiterated a buy rating last month
Copying Annabel Samimy's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +3.90% per trade.
---